Akebia Therapeutics, Inc. Announces Fourth Quarter And Full-Year 2014 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced financial results for the fourth quarter and full year ended December 31, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news